<b>Elsafty_Reports_of_Myeloid_Neoplasms_2024</b>

The online platform (<b><i>https://cbctst.com</i></b>) was used to automatically generate comprehensive clinicopathologic correlations including narrative comment/interpretation for CBC and peripheral blood smear review, diagnosis/follow-up, prognosis (molecular studies by NGS/PCR), and recommendations.<b>Elsafty_Reports_of_Myeloid_Neoplasms_2024</b> provides specialized, world-class, and comprehensive templates for myeloid neoplasms that serve purposes in Hematopathology clinical practice, teaching/training/examination, and automation, including verification and validation of relevant automated systems. This validated, up-to-date, 100% accurate, machine-readable, and novel/unprecedented dataset has been meticulously reviewed word-by-word by both Hematopathologists and attending physicians from various specialties who detect or diagnose such cases at multiple international medical centres. Such meticulous review, referencing the WHO 5th edition, the international consensus classification of myeloid neoplasms and acute leukemias, along with other relevant esteemed publications, justifies the complexity and diversity of the dataset while maintaining benchmark scientific quality.

本在线平台（<b><i>https://cbctst.com</i></b>）可自动生成涵盖全血细胞计数（Complete Blood Count, CBC）与外周血涂片复核、诊断/随访、预后评估（基于下一代测序（Next-Generation Sequencing, NGS）/聚合酶链式反应（Polymerase Chain Reaction, PCR）的分子检测）及临床建议的完整临床病理关联分析报告，包含叙述性评论与解读。<b>Elsafty_Reports_of_Myeloid_Neoplasms_2024</b> 专为髓系肿瘤提供专业化、国际顶尖且内容全面的模板，可应用于血液病理学（Hematopathology）临床实践、教学培训与考核，以及自动化流程（包括相关自动化系统的验证与确认）。此经过验证的最新数据集准确率达100%、具备机器可读性，且为新颖且前所未有的首创数据集，已由来自多家国际医疗中心的血液病理学家及多专科主治医师逐字细致审阅——这些专家负责此类病例的检出与诊断工作。本次审阅参照世界卫生组织（World Health Organization, WHO）第五版造血系统肿瘤分类标准、髓系肿瘤与急性白血病国际共识分类，以及其他权威相关出版物，既保障了数据集的复杂性与多样性，同时维持了行业标杆级的科学质量水准。

搜集汇总

背景与挑战

背景概述

该数据集是'Elsafty_Reports_of_Myeloid_Neoplasms_2024'，发布于2025年7月17日，提供骨髓肿瘤的临床病理相关性报告，通过自动化平台生成，涵盖诊断、预后和推荐等全面信息。数据集经过专家逐字审核，基于WHO第5版和国际共识分类，具有高准确性和机器可读性，适用于血液病理学实践、教学和自动化系统验证。